Found 4 matching trials
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC PHASE2 This study is a single-center, prospective, single-arm exploratory clinical...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of PD-1 in...
Show More Learn More & Join Trial
Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus PHASE2 For HCC patients with PVTT who the researchers believe can benefit from rad...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer PHASE2 In this study, we propose to use the combination of ET-SPACE NIR irradiatio...
Show More Location
Zhejiang Hospital
Learn More & Join Trial